| 5-R01-EB031935-04 |
A high-performance and versatile technology for precision microbiome engineering |
Harris Wang |
Columbia University Health Sciences |
| 5-R21-EB033595-02 |
A Molecular Grammar for Guide RNAs (gRNAs) with Engineered Secondary Structures |
Yirong Mo |
University of North Carolina Greensboro |
| 1-R01-EB037456-01 |
A molecular toolbox for thermal control of programmed cell death in animals |
Lukasz Bugaj |
University of Pennsylvania |
| 1-DP2-EB035891-01 |
A Novel Class of Synthetic Receptors to Empower the Age of mRNA Therapies |
Xiaojing Gao |
Stanford University |
| 1-R01-EB038005-01 |
A self-amplifying RNA-based synthetic nanobody platform for next-generation therapeutics |
Ahmad Khalil |
Boston University (Charles River Campus) |
| 5-R01-EB027895-05 |
Accelerating phage evolution and tools via synthetic biology and machine learning |
Sam Nugen |
Cornell University |
| 1-R01-EB038025-01A1 |
Binding-Induced Enzyme Activation for Prodrug Therapy of HER2 Variants |
Shawn Owen |
University of Utah |
| 5-R03-EB036096-02 |
Bioengineering of Customized Exosomes as a Cell-free Therapy for Volumetric Muscle Loss Injuries Proposal |
Prabaha Sikder |
Cleveland State University |
| 5-R21-EB035208-02 |
Computationally designed, small molecule-responsive cell receptors for treating solid tumors |
Anum Glasgow |
Columbia University Health Sciences |
| 1-DP1-EB038939-01 |
De novo design and engineering of biological error correction |
Tanja Kortemme |
University of California, San Francisco |
